The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.650
-0.040 (-2.37%)
At close: May 28, 2025, 4:00 PM
1.690
+0.040 (2.42%)
After-hours: May 28, 2025, 7:59 PM EDT
The Beauty Health Company Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for The Beauty Health Company stock ranges from a low of $1.00 to a high of $2.00. The average analyst price target of $1.42 forecasts a -13.94% decrease in the stock price over the next year.
Price Target: $1.42 (-13.94%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for The Beauty Health Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 3 | 3 | 2 |
| Sell | 3 | 3 | 3 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.5 → $1.25 | Hold | Maintains | $1.5 → $1.25 | -24.24% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | -9.09% | Mar 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | +6.06% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -24.24% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -39.39% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
295.23M
from 334.29M
Decreased by -11.69%
Revenue Next Year
313.13M
from 295.23M
Increased by 6.06%
EPS This Year
-0.26
from -0.36
EPS Next Year
-0.20
from -0.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 308.8M | 349.6M | 364.5M |
| Avg | 295.2M | 313.1M | 329.8M |
| Low | 275.2M | 285.5M | 300.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -7.6% | 18.4% | 16.4% |
| Avg | -11.7% | 6.1% | 5.3% |
| Low | -17.7% | -3.3% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | -0.05 | -0.17 |
| Avg | -0.26 | -0.20 | -0.17 |
| Low | -0.37 | -0.34 | -0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.